| Pharmaceutical active ingredients: |
| Desoximetasone |
| Available forms, composition and doses of Esperson: |
| Cream; Topical; Desoximetasone 0.25%Gel; Topical; Desoximetasone 0.05%Ointment; Topical; Desoximetasone 0.25% |
| Esperson medical category: |
| Human:Anti-inflammatory agentsTopical corticosteroids |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D07AB19 - DexamethasoneD07AC03 - DesoximetasoneD07XC02 - Desoximetasone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Eritromicina | Erythromycin Lactobionate | Sanofi-Aventis |
| Erkaltungsbalsam | Camphor; Eucalyptus Oil; Menthol; Pine Sylvestris Oil; Pumilio Pine Oil | Sanofi-Aventis |
| Ersefuryl | Nifuroxazide | Sanofi-Aventis |
| Espenal | Disulfiram | Sanofi-Aventis |
| Esperal | Disulfiram | Sanofi-Aventis; Nycomed; Sofarimex Industria Quimica and Farmaceutica; Torrent Pharmaceuticals |
| Esperson N | Desoximetasone; Neomycin Sulfate | Sanofi-Aventis |
| Essaproct Ointment | Chlorocarvacrol; Ichthammol; Menthol | Sanofi-Aventis |
| Essaproct Suppositories | Chamomile Oil; Chlorocarvacrol; Ichthammol; Menthol | Sanofi-Aventis |
| Essaven | Aescinate Sodium; Heparin Sodium | Sanofi-Aventis; Cassella-Med |
| Essaven 50 000 | Aesculus; Arnica; Heparin Sodium | Sanofi-Aventis; Cassella-Med |